Through AstraZeneca Exchange, mentors from AstraZeneca support Nordic entrepreneurs and start-ups to speed up innovations that benefit patients.
By sharing expertise, AstraZeneca help to move start-ups towards sustainable and successful growth.
The setup is based on arranged non confidential, single advisory sessions on strategic questions in the early start-up journey to help entrepreneurial ideas grow.
When the life science sector grows, we all grow, and patients benefit.
Sign up
Programme
17:00–17:10 |
Welcome and introduction, Morten Egeberg, SPARK Norway |
17:10–17:30 | AstraZeneca Exchange Nordics: a business and science mentoring program supporting entrepreneurs and start-ups + Q&A Pernilla Isberg, Director, Operation, AstraZeneca BioVentureHub and Mats Axelsson, Associate Director Procurement, AstraZeneca |
17:30–17:45 |
AZ Partnering and collaborating with AstraZeneca + Q&A |
17:45–18.00 | Q&A (AZ & AZ Exchange Mentoring program) |
18:00 –19:00 | Food/drinks and mingling |
Speakers
Pernilla Isberg
Pernilla is a Pharmacist with +25 years of experience from working within AstraZeneca with marketing, clinical trials and cross functional project management.
Since 2018 Pernilla is Director Operation at AZ BioVentureHub – a novel approach to open innovation which allows smaller Biotechs and academic groups to work in close proximity to the skills and capabilities that resides within big pharma.
She is also coordinating the team working with the AZ Exchange Nordic business and science mentoring program.
Mats Axelsson
In his five years at AstraZeneca, Mats Axelsson has been working across drug manufacturing, IT, Business Development, and most recently Procurement supporting AstraZeneca’s R&D units.
Katarina Emanuelsson
Katarina joined AstraZeneca in March 2015 and is currently Director Transactions in AstraZeneca’s Business Development, Licensing and Strategy team supporting the AstraZeneca BioPharmaceuticals R&D.
She has over 15 years’ experience from international pharma/biotech deal-making where she completed a large number of deals with biotech’s, pharma and academia across AstraZeneca’s strategic areas.
Before joining AstraZeneca Katarina held positions within Business Development for Japanese owned Takara Bio Europe AB, French Cellectis SA and the Swedish stem cell pioneering biotech company Cellartis AB.
Digital attendance
If you are unable to attend at 亚博娱乐官网_亚博pt手机客户端登录sparken, but will be able to attend digitally, please send an email to Torunn to get a separate registration link for zoom-participation. Please note that we encourage physical participation for the best experience of the meeting.